These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


206 related items for PubMed ID: 37909242

  • 1. Inhibiting CSF1R alleviates cerebrovascular white matter disease and cognitive impairment.
    Askew KE, Beverley J, Sigfridsson E, Szymkowiak S, Emelianova K, Dando O, Hardingham GE, Duncombe J, Hennessy E, Koudelka J, Samarasekera N, Salman RA, Smith C, Tavares AAS, Gomez-Nicola D, Kalaria RN, McColl BW, Horsburgh K.
    Glia; 2024 Feb; 72(2):375-395. PubMed ID: 37909242
    [Abstract] [Full Text] [Related]

  • 2. Minocycline protects against microgliopathy in a Csf1r haplo-insufficient mouse model of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP).
    Li X, Hu B, Guan X, Wang Z, Zhou Y, Sun H, Zhang X, Li Y, Huang X, Zhao Y, Wang X, Xu H, Zhang YW, Wang Z, Zheng H.
    J Neuroinflammation; 2023 May 31; 20(1):134. PubMed ID: 37259140
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Depletion of microglia ameliorates white matter injury and cognitive impairment in a mouse chronic cerebral hypoperfusion model.
    Kakae M, Tobori S, Morishima M, Nagayasu K, Shirakawa H, Kaneko S.
    Biochem Biophys Res Commun; 2019 Jul 05; 514(4):1040-1044. PubMed ID: 31097227
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Deficiency of Nrf2 exacerbates white matter damage and microglia/macrophage levels in a mouse model of vascular cognitive impairment.
    Sigfridsson E, Marangoni M, Hardingham GE, Horsburgh K, Fowler JH.
    J Neuroinflammation; 2020 Dec 01; 17(1):367. PubMed ID: 33261626
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology.
    Olmos-Alonso A, Schetters ST, Sri S, Askew K, Mancuso R, Vargas-Caballero M, Holscher C, Perry VH, Gomez-Nicola D.
    Brain; 2016 Mar 01; 139(Pt 3):891-907. PubMed ID: 26747862
    [Abstract] [Full Text] [Related]

  • 8. Phenotypic characterization of a Csf1r haploinsufficient mouse model of adult-onset leukodystrophy with axonal spheroids and pigmented glia (ALSP).
    Chitu V, Gokhan S, Gulinello M, Branch CA, Patil M, Basu R, Stoddart C, Mehler MF, Stanley ER.
    Neurobiol Dis; 2015 Feb 01; 74():219-28. PubMed ID: 25497733
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An Early Microglial Response Is Needed To Efficiently Control Herpes Simplex Virus Encephalitis.
    Uyar O, Laflamme N, Piret J, Venable MC, Carbonneau J, Zarrouk K, Rivest S, Boivin G.
    J Virol; 2020 Nov 09; 94(23):. PubMed ID: 32938766
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CSF1R signaling is a regulator of pathogenesis in progressive MS.
    Hagan N, Kane JL, Grover D, Woodworth L, Madore C, Saleh J, Sancho J, Liu J, Li Y, Proto J, Zelic M, Mahan A, Kothe M, Scholte AA, Fitzgerald M, Gisevius B, Haghikia A, Butovsky O, Ofengeim D.
    Cell Death Dis; 2020 Oct 23; 11(10):904. PubMed ID: 33097690
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.